Skip to content
healthcare.dev
Get a free key

Buprenorphine and Naloxone

NDC 62175-452, Buprenorphine and Naloxone, tablet, from Lannett Company, Inc..

Product NDC
62175-452
Status
Listed
Labeler
Lannett Company, Inc.
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205022
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62175-452 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE2 mg/1
  • NALOXONE.5 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
62175-452-326217504523230 TABLET in 1 BOTTLE (62175-452-32)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/14eaa94a-cc8a-4e1e-8cfb-5c976c96c606

  • NADAC price for package 62175045232

    GET /v1/drugs/nadac/62175045232

Use it

Look up 62175-452 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62175-452 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62175-452. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.